HC
GSK icon

Hara Capital’s GSK GSK Stock Holding History

Hara Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-134
Closed -$7.09K – 302
2026
Q1 		$7.46K Hold
134
– – ﹤0.01% 270
2025
Q4 		$6.63K Hold
134
– – ﹤0.01% 261
2025
Q3 		$5.78K Hold
134
– – ﹤0.01% 258
2025
Q2 		$5.15K Hold
134
– – ﹤0.01% 289
2025
Q1 		$5.19K Hold
134
– – ﹤0.01% 257
2024
Q4 		$4.53K Hold
134
– – ﹤0.01% 266
2024
Q3 		$5.48K Buy
+134
New +$5.48K ﹤0.01% 264

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Hara Capital's GSK Position: Q2 2026 in Review

Hara Capital sold out of GSK (GSK) in Q2 2026, closing a stake of 134 shares — an estimated $7.09K sold.

Hara Capital first reported a position in GSK in Q3 2024 and held it in 7 quarters. The position peaked at $7.46K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Hara Capital reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Hara Capital sold 134 GSK shares in Q2 2026, an estimated $7.09K.
  • Hara Capital first reported a position in GSK in Q3 2024 and held it in 7 quarters.
  • Hara Capital's GSK position peaked at $7.46K in Q1 2026.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.